Your browser doesn't support javascript.
loading
Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management.
Khan, Khurum H; Wong, Mabel; Rihawi, Karim; Bodla, Shankar; Morganstein, Daniel; Banerji, Udai; Molife, Lulama R.
Afiliação
  • Khan KH; Drug Development Unit, Royal Marsden National Health Service Trust, London, United Kingdom.
  • Wong M; Drug Development Unit, Royal Marsden National Health Service Trust, London, United Kingdom.
  • Rihawi K; Drug Development Unit, Royal Marsden National Health Service Trust, London, United Kingdom.
  • Bodla S; Department of Statistics, Royal Marsden National Health Service Trust, London, United Kingdom.
  • Morganstein D; Department of Endocrinology, The Royal Marsden (RM) National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Banerji U; Drug Development Unit, Royal Marsden National Health Service Trust, London, United Kingdom.
  • Molife LR; Drug Development Unit, Royal Marsden National Health Service Trust, London, United Kingdom rhoda.molife@icr.ac.uk.
Oncologist ; 21(7): 855-60, 2016 07.
Article em En | MEDLINE | ID: mdl-27151652

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Proteínas Proto-Oncogênicas c-akt / Serina-Treonina Quinases TOR / Inibidores de Fosfoinositídeo-3 Quinase / Hiperglicemia / Neoplasias Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Proteínas Proto-Oncogênicas c-akt / Serina-Treonina Quinases TOR / Inibidores de Fosfoinositídeo-3 Quinase / Hiperglicemia / Neoplasias Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article